Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States-Reference-Cited by-同舟云学术

Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States

Published:2021-01-18 Issue:4 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Fisher Arielle M.¹²,Schlauch Daniel¹²,Mulloy Matthew³,Dao Ann⁴^ORCID,Reyad Ashraf I.⁴^ORCID,Correll Mick¹²,Fromell Gregg J.²⁵,Pittman James⁵,Bingaman Adam W.⁶,Sankarapandian Balamurugan⁴⁷,Allam Sridhar R.⁴⁷^ORCID

Affiliation:

1. Genospace Boston MA USA

2. Sarah Cannon Nashville TN USA

3. Medical City Dallas Dallas TX USA

4. Medical City Fort Worth Fort Worth TX USA

5. HCA Healthcare Nashville TN USA

6. Methodist Hospital Specialty and Transplant San Antonio TX USA

7. Tarrant Nephrology Associates/Premier Physicians Group Health Fort Worth TX USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14216

Reference35 articles.

1. Johns Hopkins University coronavirus resource center. URL:https://coronavirus.jhu.edu. Accessed October 10 2020.

2. Centers for disease control and prevention. URL:https://www.cdc.gov/coronavirus/2019‐ncov/need‐extra‐precautions/index.html. Accessed October 10 2020.

3. COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter

4. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center

5. COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19;Frontiers in Medicine;2024-04-03

2. Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024;MMWR. Morbidity and Mortality Weekly Report;2024-03-28

3. Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance;Journal of Infection;2024-03

4. Long‐term outcomes after COVID‐19 infection in transplant recipients;Clinical Transplantation;2024-02

5. Incorporating Translational Data into Immunosuppression Decisions During COVID-19;Current Transplantation Reports;2023-11-07